Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-12 |
mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.24 | 4e-12 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-12 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-11 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-10 |
mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-10 |
mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-10 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-10 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-09 |
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-09 |